Literature DB >> 24648586

Effects of bupivacaine versus levobupivacaine on pulmonary function in patients with chronic obstructive pulmonary disease undergoing urologic surgery: a randomized, double-blind, controlled trial.

Sevtap Hekimoglu Sahin1, Mehmet Inal1, Aysin Alagol2, Alkin Colak1, Cavidan Arar1, Tughan Basmergen1, Isil Gunday1, F Nesrin Turan3.   

Abstract

BACKGROUND: There are limited data to determine the impact of subarachnoid blockade with local anesthetics on perioperative pulmonary function. The effects of local anesthetics used in spinal anesthesia are very important in terms of respiratory function in patients with chronic obstructive pulmonary disease (COPD).
OBJECTIVE: The aim of this study was to evaluate the effects of bupivacaine versus levobupivacaine on pulmonary function in patients with COPD undergoing urologic surgery.
METHODS: Patients were randomized into 2 groups: group B (n = 25) received 3 mL of hyperbaric 0.5% bupivacaine; group L (n = 25) received 3 mL of isobaric 0.5% levobupivacaine. Both agents were administered intrathecally. Forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), peak expiratory flow rate (PEFR), vital capacity (VC), and FEV1/FVC ratio were measured using spirometry 10 and 30 minutes after spinal anesthesia and 30 minutes after completion of the operation. An arterial blood gas test was performed before and after spinal anesthesia.
RESULTS: Fifty male patients aged 40 to 80 years completed the study. There were no differences in the results of preoperative and postoperative FVC, FEV1, PEFR, VC, FEV1/FVC ratio, and arterial blood gas between the bupivacaine (n = 25) and levobupivacaine (n = 25) groups. However, patients who took bupivacaine showed a significant decrease in intraoperative PEFR at 30 minutes compared with baseline, a result not seen in patients who took levobupivacaine (P = 0.036 and P = 0.282, respectively).
CONCLUSIONS: In 50 patients with moderate COPD undergoing urologic surgery, hyperbaric bupivacaine caused a decrease in intraoperative PEFR compared with baseline because of higher level block; however, the effects of hyperbaric bupivacaine and isobaric levobupivacaine on pulmonary function in these patients showed equally effective potencies for spinal anesthesia.

Entities:  

Keywords:  bupivacaine; chronic obstructive pulmonary disease; levobupivacaine; respiratory function tests

Year:  2011        PMID: 24648586      PMCID: PMC3957160          DOI: 10.1016/j.curtheres.2011.06.003

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN: 0011-393X


  12 in total

1.  Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update.

Authors:  L M Fabbri; S S Hurd
Journal:  Eur Respir J       Date:  2003-07       Impact factor: 16.671

2.  The effect of intrathecal fentanyl added to hyperbaric bupivacaine on maternal respiratory function during Cesarean section.

Authors:  Y-C P Arai; J Ogata; K Fukunaga; A Shimazu; A Fujioka; T Uchida
Journal:  Acta Anaesthesiol Scand       Date:  2006-03       Impact factor: 2.105

3.  Levobupivacaine and bupivacaine in spinal anesthesia for transurethral endoscopic surgery.

Authors:  Opas Vanna; Lamai Chumsang; Sarinra Thongmee
Journal:  J Med Assoc Thai       Date:  2006-08

4.  The effect of spinal anesthesia on the pulmonary function of patients with chronic obstructive pulmonary disease.

Authors:  S Paskin; T Rodman; T C Smith
Journal:  Ann Surg       Date:  1969-01       Impact factor: 12.969

5.  Standardized lung function testing. Official statement of the European Respiratory Society.

Authors: 
Journal:  Eur Respir J Suppl       Date:  1993-03

6.  Interaction between baricity (glucose concentration) and other factors influencing intrathecal drug spread.

Authors:  P Sanderson; J Read; D G Littlewood; D McKeown; J A Wildsmith
Journal:  Br J Anaesth       Date:  1994-12       Impact factor: 9.166

7.  Non-invasive ventilation corrects alveolar hypoventilation during spinal anesthesia.

Authors:  Martine Ferrandière; Eric Hazouard; Jean Ayoub; Marc Laffon; John Gage; Colette Mercier; Jacques Fusciardi
Journal:  Can J Anaesth       Date:  2006-04       Impact factor: 5.063

Review 8.  Levobupivacaine.

Authors:  G Ivani; B Borghi; H van Oven
Journal:  Minerva Anestesiol       Date:  2001-09       Impact factor: 3.051

9.  Regional anaesthesia and cough effectiveness. A study in patients undergoing caesarean section.

Authors:  A W Harrop-Griffiths; A Ravalia; D A Browne; P N Robinson
Journal:  Anaesthesia       Date:  1991-01       Impact factor: 6.955

10.  Levobupivacaine versus racemic bupivacaine in spinal anaesthesia for urological surgery.

Authors:  Y Y Lee; K Muchhal; C K Chan
Journal:  Anaesth Intensive Care       Date:  2003-12       Impact factor: 1.669

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.